应用子宫托预防单胎妊娠早产(PoPPS):随机对照试验
本研究为开放标签多中心随机对照试验,纳入妊娠18+0至23+6周、经阴道超声宫颈长度≤25 mm且无既往自发性早产史的单胎无症状孕妇,随机分为Bioteque杯状子宫托组与无子宫托组,主要结局为37周前早产。结果显示两组37周前早产率无显著差异(43% vs 40%;相对风险1.09;95%CI 0.71-1.68),作者结论为子宫托使用与早产预防无关,但该试验样本量小、把握度不足且提前终止。
要点
- 单胎、宫颈长度≤25 mm且无既往自发性早产史者,子宫托组37周前早产率43% vs 无子宫托组40%,无显著差异。
- 相对风险1.09(95%CI 0.71-1.68),34周前、28周前早产率、分娩孕周、出生体重及新生儿复合不良结局均无显著差异。
- 该试验样本量小、把握度不足且提前终止,作者认为子宫托使用与早产预防无关。
核心结论
- 在这项样本量小、把握度不足的随机对照试验中,子宫托使用与单胎妊娠、经阴道超声宫颈短且无既往自发性早产史女性的早产预防无关。
研究设计与样本
- 开放标签多中心随机对照试验,纳入妊娠18+0至23+6周、经阴道超声宫颈长度≤25 mm且无既往自发性早产史的无症状单胎妊娠孕妇。
- 受试者随机接受Bioteque杯状子宫托或不使用子宫托,子宫托由经过培训的母胎医学人员放置。
- 宫颈长度≤20 mm者推荐使用阴道孕酮。
- 主要结局为37周前早产;每组需121例(共242例)以检测主要结局从无子宫托组的30%降至子宫托组的15%。
- 试验在完成入组前提前终止;2014年3月17日至2016年7月29日期间共17383名女性接受经阴道超声宫颈长度测量。
主要发现
- 17383名接受宫颈长度测量者中,422名(2.4%)宫颈长度≤25 mm,391名(92.7%)符合全部入选标准,其中122名(31.2%)同意随机分组。
- 61名(50%)随机分入子宫托组,61名(50%)分入无子宫托组,两组基线特征相似。
- 子宫托组与无子宫托组37周前早产率无显著差异(43% vs 40%;相对风险1.09;95%CI 0.71-1.68)。
- 两组34周前早产率、28周前早产率、分娩孕周、出生体重及新生儿复合不良结局率等次要结局均无显著差异。
临床怎么用
- 作者结论为子宫托使用与早产预防无关,原文未据此给出推荐。
局限性
- 原文明确指出该试验样本量小且把握度不足。
- 试验在完成入组前提前终止。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine if pessary use prevents preterm birth (PTB) in women with singleton pregnancy, with short cervical length (CL) measured on transvaginal sonography (TVS) and without prior spontaneous PTB (sPTB). METHODS: This was an open-label multicenter randomized trial of asymptomatic women presenting at 18 + 0 to 23 + 6 weeks' gestation with a singleton pregnancy, CL ≤ 25 mm on TVS and no prior sPTB. sPTB included those with spontaneous onset of labor and those with rupture of membranes prior to labor. Subjects were randomized to receive either a Bioteque cup pessary or no pessary. Pessaries were inserted by trained maternal-fetal medicine staff. Vaginal progesterone was recommended to women with CL ≤ 20 mm. The primary outcome was PTB < 37 weeks. A sample size of 121 women in each group (n = 242) was needed to detect a reduction in the primary outcome from 30% in the no-pessary group to 15% in the pessary group. The trial was stopped early before complete enrollment. RESULTS: Between 17 March 2014 and 29 July 2016, 17 383 women underwent CL measurement on TVS. Of these, 422 (2.4%) had CL ≤ 25 mm and 391 (92.7%) met the full eligibility criteria, of which 122 (31.2%) agreed to randomization. Sixty-one (50%) women were randomized to the pessary group and 61 (50%) to the no-pessary group. Baseline characteristics were similar between the groups. There were no significant differences between the pessary and no-pessary groups in the rate of PTB < 37 weeks (43% vs 40%; relative risk 1.09; 95% CI, 0.71-1.68) or in secondary outcomes, such as rate of PTB < 34 weeks, rate of PTB < 28 weeks, gestational age at delivery, birth weight and rate of composite adverse neonatal outcome. CONCLUSIONS: Cervical pessary use was not associated with prevention of PTB in women with a singleton pregnancy, short CL on TVS and no prior sPTB in this small, underpowered randomized controlled trial. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Dugoff L, Berghella V, Sehdev H, et al. Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial. Ultrasound Obstet Gynecol. 2018. PMID: 28940481. doi:10.1002/uog.18908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。